As the House Judiciary Committee meets today to discuss pharmaceutical innovation and access, this is the key overarching reality: STRONG PATENT AND INTELLECTUAL PROPERTY (IP) RIGHTS SPUR INNOVATION AND MAKE DRUGS *MORE* AVAILABLE TO U.S. CONSUMERS, NOT LESS. This is a no-brainer.
https://t.co/9JtAgqjdo2
"We are already charging much of our spending to future generations through debt. But voters, need it be said, would be even more likely to support profligate spending knowing they didn't have any federal tax bill." -@davidharsanyi https://t.co/6hSGRx9wTO
"The autopsy should have been an opportunity to examine how the Democratic Party got itself into such a situation in 2024. Instead, the document is unfinished, sloppy and lacking in curiosity about almost everything." https://t.co/4NmLsXFdVD
Humira didn't become a treatment for multiple inflammatory diseases by accident. AbbVie invested years into additional clinical trials, formulations, and regulatory approvals. None of this would have been possible without strong and secure patent rights.
.@CMSInnovates has been overriding patient choice with mandated experiments that leave doctors and patients with no flexibility for more than a decade. That’s why CFIF urges Congress to pass HR 8293 and eliminate CMMI for good. https://t.co/ZjMZY2O4SD
The 340B Drug Pricing Program has grown from 39 participating hospitals in 1992 to 2,954 in 2024.
Contract pharmacies went from one in 1995 to 32,528 in 2024. Drug purchases at the 340B discounted price increased from $5 billion in 2010 to $81.4 billion in 2024.
https://t.co/WOB0UjLGus
Along with the Center for Individual Freedom yesterday I filed an amicus brief in the Suncor v. Boulder County case that addresses the consumer protection issues that are not directly before SCOTUS but have been stayed in the lower courts awaiting resolution of the public nuisance claims.
U.S. companies should not be forced to subsidize their local competitors if they want to participate in the Canadian market. @RepSmucker's Protecting American Streaming and Innovation Act deserves serious consideration.
Canada is doubling down on discriminatory regulations targeting American streaming services and digital creators.
A top Canadian regulator confirmed new rules implementing Canada's discriminatory Online Streaming Act are coming soon.
That’s why I introduced the Protecting American Streaming and Innovation Act to authorize a Section 301 investigation into these harmful policies, and I will keep fighting to defend free expression, innovation, and American jobs.
"The results of a recent study...show that a mandated transition away from plastic packaging is not just a minor adjustment for manufacturers; it is a major financial shock for consumers." $1,382 in additional costs annually at the grocery store! https://t.co/BdN0dBKXM4
If drug innovators must provide enormous discounts on their manufactured products, why aren’t patients seeing lower prices as a result of the #340B program? https://t.co/T5xjwDEWUf
"About 80% of the rise in prices over the past six years has been under Biden's presidency. So, if you're angry about the high price of nearly everything, Bidenomics is the primary villain." https://t.co/s0rYsbngFX
NEW @CFIFonline podcast featuring @ProfKOsenga on how strong patent protections drive investment and innovation & the role of injunctions in patent litigation. The podcast also addresses key myths about patents. https://t.co/8uoo3kvQvW